Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system.
OBJECTIVE
Opioid overdoses (ODs) have been increasing, and harm reduction efforts are a priority. The success of these efforts will be dependent on the identification of at-risk patients and improved access to the antidote naloxone. Therefore, to identify access to naloxone and factors associated with negative health outcomes, we conducted a retrospective study of patients with OD to identify those at highest risk of adverse outcomes and to assess the use of naloxone.


METHODS
We conducted a study of electronic health records for patients admitted to the largest multihospital system in the region - the Geisinger Health System (GHS) for ODs - from April 2005 through March 2015. ODs were defined by International Classification of Diseases-9 codes (age range: 10-95 years). Bivariate analyses and multiple logistic regressions were conducted to identify pre-OD factors associated with adverse health outcomes post-OD.


RESULTS
We identified 2,039 patients with one or more ODs, of whom 9.4% were deceased within 12 months. Patient demographics suggest that patients with OD had a mean age of 52 years, were not married (64%), and were unemployed (78%). Common comorbidities among patients with OD include cardiovascular disease (22%), diabetes (14%), cancer (13%), and the presence of one or more mental health disorders (35%). Few patients had a prescription order for naloxone (9%) after their OD. The majority of patients with OD were in proximity to GHS health care facilities, with 87% having a GHS primary care provider. In multiple logistic regressions, common predictors of adverse outcomes, including death, repeated ODs, frequent service use, and high service cost, were higher prescription opioid use, comorbid medical conditions, comorbid mental disorders, and concurrent use of other psychotropic medications.


CONCLUSIONS
This study suggests opportunities for improving OD outcomes. Those who receive higher quantities of prescription opioids concurrent with other psychotropic medicines may need closer monitoring to avoid death, repeated OD events, higher service use, and higher service costs. Other opportunities for improving OD outcomes include the use of electronic health records to notify physicians of high-risk patients and updating of guidelines/operation manuals focused on the distribution of naloxone to those in highest need.
Center for Health Research.
Joseph A
JA
Boscarino
Biomedical and Translational Informatics, Geisinger Clinic, Danville, PA.
H Lester
HL
Kirchner
Center for Health Research.
James M
JM
Pitcavage
Indivior Inc., Richmond, VA.
Vijay R
VR
Nadipelli
Indivior Inc., Richmond, VA.
Naoko A
NA
Ronquest
Emergency Medicine Service Line, Central Division, Geisinger Clinic, Danville.
Michael H
MH
Fitzpatrick
Geisinger Interventional Pain Center, Danville, PA, USA.
John J
JJ
Han
health care access; health care costs; naloxone; opioids; overdose antidote; prescription drugs; services utilization
Psychiatr Serv. 2015 Nov;66(11):1149-54
26129993
JAMA. 2016 Jun 14;315(22):2415-23
27299617
J Pain Res. 2015 Jul 09;8:361-73
26185467
J Clin Epidemiol. 2004 Dec;57(12):1288-94
15617955
JAMA. 2013 Oct 9;310(14):1433-4
24104358
Health Aff (Millwood). 2015 Oct;34(10 ):1624-7
26438736
Subst Abuse Rehabil. 2015 Aug 19;6:83-91
26316838
Am J Emerg Med. 2014 Oct;32(10):1168-73
25154346
Pain Res Manag. 2015 Sep-Oct;20(5):234-40
26291127
Ann Intern Med. 2016 Jan 5;164(1):1-9
26720742
Annu Rev Public Health. 2016;37:61-81
26667605
Pain Med. 2015 Aug;16(8):1566-79
26077738
J Pain Res. 2015 Aug 12;8:523-35
26316803
Psychiatr Serv. 2016 Jul 1;67(7):749-57
27079987
Ann Intern Med. 2011 Sep 6;155(5):325-8
21893626
Addiction. 2010 Oct;105(10):1783-4
20860077
Am J Emerg Med. 2016 Jan;34(1):30-5
26476578
Pain Physician. 2010 Sep-Oct;13(5):401-35
20859312
BMC Health Serv Res. 2006 Apr 04;6:46
16595013
Am J Public Health. 2015 Jul;105 Suppl 3:e26-32
25905856
Ther Adv Drug Saf. 2015 Feb;6(1):20-31
25642320
Subst Abus. 2015 ;36(2):240-53
25774771
JAMA. 2016 Apr 19;315(15):1577-9
26978227
Am J Emerg Med. 2010 Mar;28(3):296-303
20223386
JAMA. 2011 Apr 6;305(13):1315-21
21467284
Am Health Drug Benefits. 2009 Jun;2(4):174-80
25126289
Pain Med. 2014 Oct;15(10):1765-70
25139712
Popul Health Manag. 2014 Dec;17(6):372-87
25075734
Addiction. 2010 Oct;105(10):1776-82
20712819